Cause analysis and improvement of unqualified specimens in blood transfusion department
-
摘要: 目的：探讨分析临床输血不合格标本产生的原因，保证临床用血安全。方法：选取2012年1-12月期间西安市红会医院输血科接收临床输血样本9 211例，对不合格标本进行原因分析，并指定出改进方案。结果：统计分析2012年上半年和下半年拒收例数分别为107例和24例，同比下降63.34%。样本不合格因素包括：申请单信息有误、血型填写错误、医师未签字、血样信息有误、血量不足、样本溶血、血样无标识。各指标下半年较上半年下降率分别为：28.25%、8.16%、4.58%、14.50%、2.29%、2.29%、4.01%。结论：严格执行输血前样本审核制度，保证临床输血安全有效。Abstract: Objective: To investigate the reason of unqualified specimen of blood transfusion, and ensure the safety of blood for clinical use. Method: From January to December, 2012, the Department of Blood Transfusion, Xi'an City Red Cross Hospital received 9 211 clinical blood samples, analyzed the reasons of unqualified specimen, and specified the improvement plan.Result: The rejected cases of the first and the second half of 2012 were 107 cases and 24 cases, dropped by 63.34%. The factors of unqualified sample included:fill in error of application form, error of blood type information, lack of physician's signature, error of blood sample information, insufficient blood volume, hemolytic sample and blood sample without mark. Compared to the first half, the decreased rates of each index in the second half were:28.25%, 8.16%, 4.58%, 14.50%, 2.29%, 2.29% and 4.01%. Conclusion: It should to strict perform the audit system of samples before transfusion, to ensure the effective and safe clinical transfusion.
-
-
[1] KENNEDY R, CELIS E.Multiple roles for CD4+ T cells in anti-tumor immune responses[J].Rev, 2008,222:129-144.
[2] LEFRANCOIS L. Development, trafficking, and function of memory T-cell subsets[J].Immunol Rev,2006,211:93-103.
[3] KENNEDY R, CELIS E.Multiple roles for CD4+ T cells in anti-tumor immune responses[J].Rev,2008,222:129-144.
[4] ZHENG X, GAO J X, CHANG X, et al. B7-CD28 interaction promotes proliferation and survival but suppresses differentiation of CD4-CD8-T cells in the thymus[J]. J Immunol,2004,173:2253-2261.
[5] RUDD C E, TAYLOR A, SCHNEIDER H.CD28 and CTLA-4 coreceptor expression and signal transduction[J]. Immunol Rev, 2009,229:12-26.
[6] RAITAKARI M,BROWN RD,SZE D,et al.T-cell expansions in patients with multiple myeloma have a phenotype of cytotoxic T cells[J].Br J Haematol, 2000,110:203-209.
[7] VAN DER VLIET H J, KOON H B, ATKINS M B, et al. Exploiting regulatory T-cell populations for the immunotherapy of cancer.[J] Immunother, 2007,30:591-595.
[8] SANDEL M H, SPEETJENS F M, MENON A G,et al.Natural killer cells infiltrating colorectal cancer and MHC class I expression[J].Mol Immunol, 2005,42:541-546.
-
计量
- 文章访问数: 147
- PDF下载数: 70
- 施引文献: 0
下载: